
Episode #21
Ep 21: From wrinkles to longevity: Dominik Thor, President, Geneva College of Longevity Science
The visit to a clinic may start with a wrinkle, but a longevity doctor can turn that into a larger conversation around what’s happening inside the body, says Dr. Dominik Thor , a Swiss pharmacist and doctoral economist, and President, Geneva College of Longevity Science (GCLS) . He talks to Gen Seasoned’s Anuradha Varma about the need for a dedicated higher education centre in the field of longevity, while decoding buzzwords like “peptides”, the growing trend of longevity clinics and the stress-ageing loop. He also believes Eastern medicine and Indian ayurveda can contribute to the next wave of preventive medicine. Listen in! Timestamps: 00:51 – About the Geneva College of Longevity Science (GCLS) — the world's first academic institute dedicated to longevity science 02:16 – Who GCLS trains: doctors, physiotherapists, nutritionists, entrepreneurs 03:48 – Why longevity is such a broad, hard-to-pin-down field 06:33 – Why the beauty industry is embracing longevity and objective measurement 07:10 – New diagnostics, wearables, and the quantified-self trend 08:02 – Preventive healthcare and rebuilding trust after COVID 09:49 – Inside longevity clinics: from solo doctors to hospital-scale setups 13:44 – Exposome, genetics, and the need for retesting over time 16:18 – What to ask before choosing a longevity doctor 17:04 – Which medical specialties feed into longevity medicine 19:23 – How regulation (e.g. peptides) differs country to country 20:19 – GCLS's academic partnerships (Gulf Medical University, UAE and more) 22:15 – GCLS's new Medical PhD in Longevity Science 23:29 – Dominik's own path into longevity science 26:48 – Starting with a master's — and who GCLS's students really are 28:15 – Why India is a natural market for longevity (Ayurveda, integrative medicine) 31:13 – The "stress-aging loop" and the rise of peptide therapeutics 34:31 – What peptides actually are, explained simply 37:01 – GLP-1s vs. gray-market peptides — legality varies by country 38:49 – What longevity medicine could look like in a few years 39:32 – Body positivity, GLP-1s, and the health-vs-aesthetics debate 43:22 – Why dermatology and beauty are a "gateway" into longevity 46:02 – The risk of brands slapping "longevity" on old products 46:45 – Senescent cells and the biology behind wrinkles 48:15 – Mayo Clinic and Stanford's longevity-aesthetics research 51:17 – What excites Dominik most about the field's growth To get in touch, email genseasoned@gmail.com Disclaimer: Views are personal. Listener discretion is advised.

